The future of cancer research

Watch on YouTube
In partnership with Intel

Intel employee Bryce Olson was diagnosed with stage 4 prostate cancer. When the standard of care didn’t work, Bryce turned to genomic sequencing which allowed his doctors to identify specific genetic drivers of his disease and specific treatments and clinical trials that were a fit for his cancer. This precision medicine approach helped send his cancer into remission for several years.

Now that his cancer has returned, Bryce is working with the Broad Institute and other leaders in the field of advanced cancer research to use artificial intelligence powered by Intel technology to discover new, innovative solutions that can help him and millions of others like him around the world.

Learn more about the work Intel is doing to power the future of healthcare intelligence at

Subscribe to Freethink for more great stories